Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Active, closed
Janssen Research & Development, LLC
Phase 3
350
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia
2022-01-19
By invitation
Centre for Neuro Skills
Phase 1/2
190
California
2022-01-18
Recruiting
MedtronicNeuro
Not applicable
300
Indiana, Louisiana, Minnesota, Ohio, Texas
2022-01-18
Active, closed
Bristol-Myers Squibb
Phase 2
19
Alabama
2022-01-17
Active, closed
ALX Oncology Inc.
Phase 2/3
127
California, Tennessee, Virginia, Washington
2022-01-15
Active, closed
Vibrato Medical, Inc.
Not applicable
12
California
2022-01-14
By invitation
AbbVie
Phase 3
1,200
Alabama, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida, Georgia
2022-01-14
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
290
Arizona, California, Florida, Illinois, Kentucky, Maryland, Massachusetts, Michigan
2022-01-14
Recruiting
AbbVie
Phase 3
1,059
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia, Florida
2022-01-13
Active, closed
AbbVie
Phase 3
735
Arizona, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Illinois
2022-01-13
Active, closed
Guardant Health, Inc.
Observational
12,000
Alabama, Arkansas, California, Connecticut, District of Columbia, Florida, Georgia, Illinois
2022-01-13
Active, closed
Immunic AG
Phase 3
1,100
Florida
2022-01-12
Active, closed
Noema Pharma AG
Phase 2/3
166
California, Florida, Georgia, Massachusetts, Nevada, New York, Ohio
2022-01-11
Active, closed
Ascendis Pharma Oncology Division A/S
Phase 1/2
320
California, Illinois, Kentucky, Massachusetts, New Jersey, New York, North Carolina, Ohio
2022-01-11
Active, closed
SK Life Science, Inc.
Phase 3
140
Arizona, California, Connecticut, Georgia, Maryland, Minnesota, New Jersey, New York
2022-01-10
Recruiting
Aroa Biosurgery Limited
Observational
800
Arizona, California, Florida, Georgia, Iowa, Louisiana, Maryland, New York
2022-01-10
Active, closed
Prokidney
Phase 3
685
Alabama, Arizona, California, Delaware, Florida, Georgia, Idaho, Illinois
2022-01-05
Recruiting
Nuvalent Inc.
Phase 1/2
359
California, Colorado, District of Columbia, Florida, Illinois, Massachusetts, Michigan, Missouri
2022-01-04
Recruiting
Shockwave Medical, Inc.
Not applicable
380
Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia, Illinois
2022-01-04
Recruiting
EyePoint Pharmaceuticals, Inc.
Phase 4
60
California, Massachusetts, Mississippi, Nebraska, New York, South Carolina
2022-01-04
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
151
Arizona, Indiana, Maryland, Massachusetts, New York, North Carolina, Oregon, Washington
2022-01-04
Recruiting
PharmaIN
Phase 1
74
Arizona, California, Louisiana, Minnesota, Ohio, Pennsylvania, Texas
2022-01-03
Active, closed
Takeda
Observational
100
Massachusetts
2022-01-01
Recruiting
Rinsada
Not applicable
33
Pennsylvania
2022-01-01
By invitation
InGeneron, Inc.
Not applicable
246
Arizona, California, Florida, Georgia, Louisiana, South Dakota, Texas
2022-01-01
Active, closed
Reparel
Not applicable
50
California
2022-01-01
Not yet open
R3 Stem Cell
Not applicable
200
California
2022-01-01
Active, closed
23andMe, Inc.
Phase 1/2
141
California, Georgia, Michigan, New York, Oregon, Tennessee, Texas, Virginia
2021-12-29
Active, closed
Ono Pharmaceutical Co., Ltd.
Phase 2
119
Alabama, Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Georgia
2021-12-29
Active, closed
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
Phase 1
20
Maryland
2021-12-28
Active, closed
Pfizer
Phase 4
76
California
2021-12-28
Active, closed
AbbVie
Phase 2
210
Arizona, Arkansas, California, Connecticut, Florida, Indiana, Massachusetts, Michigan
2021-12-28
Active, closed
ModernaTX, Inc.
Phase 1/2
867
Alabama, California, Florida, Georgia, Idaho, Illinois, Indiana, Iowa
2021-12-28
Recruiting
Novartis Pharmaceuticals
Phase 1/2
34
Indiana, Massachusetts, Mississippi, New York, Ohio, Pennsylvania, Texas, Utah
2021-12-27
Active, closed
Woolsey Pharmaceuticals
Phase 2
40
Arizona, Colorado, Florida, Illinois, Kentucky, Missouri, New York
2021-12-22
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 1/2
71
California, Colorado, Illinois, Massachusetts, North Carolina, Texas
2021-12-22
Active, closed
Sangamo Therapeutics
Observational
8
California, Georgia, Massachusetts, Michigan, Minnesota
2021-12-21
Active, closed
Orano Med LLC
Phase 2
69
Colorado, Florida, Louisiana, Texas
2021-12-21
Active, closed
ITM Solucin GmbH
Phase 3
259
California, Colorado, Florida, Massachusetts, Minnesota, Missouri, New York, North Carolina
2021-12-21
Active, closed
Smith & Nephew, Inc.
Observational
299
Georgia, Massachusetts, Michigan, New York, North Carolina, Oregon, South Carolina, Tennessee
2021-12-21
Active, closed
Boston Scientific Corporation
Not applicable
500
Florida, Kansas, Michigan, New Jersey, Pennsylvania, South Carolina
2021-12-21
Active, closed
Medtronic Neurovascular Clinical Affairs
Observational
246
Alabama, Connecticut, Florida, Georgia, Illinois, Kentucky, Missouri, New York
2021-12-20
By invitation
AbbVie
Phase 2
116
Arizona, California, Georgia, Maryland, Massachusetts, Minnesota, Nevada, New Mexico
2021-12-20
Active, closed
Eli Lilly and Company
Phase 3
152
California, Florida, Massachusetts, Minnesota, New York, Pennsylvania, Tennessee, Texas
2021-12-20
Recruiting
Vasomune Therapeutics, Inc.
Phase 2
120
California, Colorado, Maryland, Michigan, Ohio
2021-12-20
Active, closed
Agios Pharmaceuticals, Inc.
Phase 3
194
California, Massachusetts, New York, North Carolina, Pennsylvania
2021-12-20
Recruiting
Merck Sharp & Dohme LLC
Phase 1
830
Florida, Michigan, New Jersey, New York, Virginia, Wisconsin
2021-12-17
Active, closed
Chiesi Farmaceutici S.p.A.
Phase 3
69
Alabama, California, Florida, Georgia, Massachusetts, Michigan, Minnesota, Missouri
2021-12-17
Active, closed
Sanofi
Phase 4
1,339
Alabama, Arizona, California, Florida, Georgia, Illinois, Kentucky, Louisiana
2021-12-16
Active, closed
Novartis Pharmaceuticals
Phase 3
1,000
Arizona, Arkansas, California, Colorado, Delaware, District of Columbia, Florida, Illinois
2021-12-16
Active, closed
Fusion Pharmaceuticals Inc.
Phase 2
115
Nebraska, Texas
2021-12-16
By invitation
Kite, A Gilead Company
Observational
1,500
Arizona, California, Colorado, District of Columbia, Florida, Illinois, Iowa, Kansas
2021-12-15
Recruiting
ViTAA Medical Solutions
Observational
200
Alabama, Massachusetts, North Carolina, Washington
2021-12-15
Active, closed
Exact Sciences Corporation
Observational
1,017
California, Florida, Illinois, Iowa, Kansas, Maryland, Minnesota, Missouri
2021-12-15
Active, closed
Pfizer
Observational
1
New York
2021-12-15
Recruiting
Taiho Oncology, Inc.
Phase 1
18
Texas
2021-12-15
Recruiting
Novartis Pharmaceuticals
Observational
867
California
2021-12-15
Active, closed
GlaxoSmithKline
Phase 2
360
California, Colorado, Massachusetts, Michigan
2021-12-14
Recruiting
Genentech, Inc.
Phase 4
188
Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Iowa
2021-12-14
Recruiting
Exelixis
Phase 1
1,394
Arizona, California, Colorado, Connecticut, Delaware, Florida, Illinois, Indiana
2021-12-14
Active, closed
Regeneron Pharmaceuticals
Phase 3
288
Arizona, California, Colorado, Florida, Illinois, Michigan, Ohio, Pennsylvania
2021-12-14
Active, closed
Novartis Pharmaceuticals
Phase 3
1,007
Arizona, California, Colorado, Connecticut, District of Columbia, Florida, Indiana, Kansas
2021-12-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
643
Arizona, California, Connecticut, Florida, Georgia, Illinois, Indiana, Kentucky
2021-12-13
Active, closed
HUYABIO International, LLC.
Phase 1
42
California, Florida, Ohio, Texas, Virginia
2021-12-13
Active, closed
Alnylam Pharmaceuticals
Observational
207
Arizona, District of Columbia, Massachusetts, Minnesota, Ohio, Pennsylvania, Texas
2021-12-13
Active, closed
Overseas Pharmaceuticals, Ltd.
Phase 3
500
California, Florida, South Carolina, Virginia
2021-12-10
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 3
500
Alabama, California, District of Columbia, Florida, Georgia, Kentucky, Massachusetts, New Mexico
2021-12-10
Active, closed
AstraZeneca
Phase 2
126
California, Georgia, Idaho, Massachusetts, Michigan, New York, Oregon, Texas
2021-12-10
Active, closed
Hologic, Inc.
Not applicable
7,500
Arizona, Florida, Kentucky, Maryland, Michigan, New York, North Carolina, Ohio
2021-12-10
Recruiting
Ono Pharmaceutical Co., Ltd.
Phase 1
217
Alabama, California, Connecticut, Georgia, Massachusetts, Michigan, Missouri, New Jersey
2021-12-10
Recruiting
4D Molecular Therapeutics
Phase 1/2
215
Arizona, California, Colorado, Florida, Illinois, Indiana, Maryland, Massachusetts
2021-12-09
Active, closed
GRAIL, Inc.
Not applicable
35,883
California, Colorado, District of Columbia, Florida, Georgia, Illinois, Louisiana, Maryland
2021-12-08
Recruiting
Immunolight, LLC
Phase 1
52
District of Columbia, North Carolina, South Carolina
2021-12-08
Recruiting
Relay Therapeutics, Inc.
Phase 1
930
Arizona, California, Colorado, Connecticut, Florida, Illinois, Indiana, Massachusetts
2021-12-08
Recruiting
UCB Biopharma SRL
Phase 3
350
Arizona, Arkansas, California, Connecticut, District of Columbia, Florida, Hawaii, Idaho
2021-12-07
Active, closed
Alessa Therapeutics Inc.
Phase 1
20
Maryland
2021-12-07
Active, closed
Sanofi
Phase 2
22
California, District of Columbia, Florida, Massachusetts
2021-12-07
Active, closed
Novita Pharmaceuticals, Inc.
Phase 1/2
121
Arizona, Arkansas, California, Connecticut, Florida, Indiana, Kansas, Michigan
2021-12-07
By invitation
QED Therapeutics, a BridgeBio company
Phase 2
300
California, Colorado, Delaware, Maryland, Missouri, Ohio, Tennessee, Wisconsin
2021-12-06
Active, closed
Cerenome
Phase 1
18
Illinois, New York, Ohio, Texas
2021-12-06
By invitation
Tobias Moeller-Bertram
Observational
3,000
California
2021-12-05
Active, closed
Organon and Co
Phase 3
58
Arkansas, California, Florida, Illinois, Indiana, Ohio, Oregon, Washington
2021-12-02
Recruiting
TiumBio Co., Ltd.
Phase 1/2
240
Texas
2021-12-02
Recruiting
H. Lundbeck A/S
Phase 3
600
Connecticut, Florida, Kentucky, Maryland, Michigan, New York, North Carolina, Ohio
2021-12-01
Recruiting
Pregistry
Observational
2,000
California
2021-12-01
Active, closed
Nerviano Medical Sciences
Phase 1/2
150
Arizona, California, Florida, Massachusetts, Minnesota, New York, Texas, Utah
2021-12-01
Active, closed
Amgen
Phase 2
222
Alabama, Arkansas, Delaware, Florida, Georgia, Iowa, Massachusetts, Michigan
2021-12-01
Active, closed
Rebiscan, Inc.
Observational
200
Virginia
2021-12-01
Recruiting
Cardiac Implants LLC
Not applicable
15
New Jersey, New York
2021-12
Recruiting
Blueprint Medicines Corporation
Phase 2/3
534
Alabama, California, Colorado, Georgia, Massachusetts, Michigan, Minnesota, New York
2021-11-30
Active, closed
Agios Pharmaceuticals, Inc.
Phase 3
258
Arizona, California, Massachusetts, Michigan, New York, North Carolina, Pennsylvania, Washington
2021-11-30
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
228
California, Connecticut, Kentucky, Maryland, New Jersey, New York, North Carolina, Ohio
2021-11-30
Recruiting
Inspire Medical Systems, Inc.
Observational
60
Colorado, Georgia, North Carolina, Ohio, Pennsylvania, Texas, Virginia
2021-11-30
Active, closed
Ultragenyx Pharmaceutical Inc
Observational
150
Arizona, California, Colorado, Florida, Georgia, Illinois, Massachusetts, Minnesota
2021-11-30
Active, closed
Invitae Corporation
Observational
400
Indiana, North Carolina
2021-11-29
Recruiting
Medaxis, LLC
Not applicable
180
Florida
2021-11-29
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, District of Columbia
2021-11-23
Recruiting
VastBiome
Observational
800
Kentucky
2021-11-22
Active, closed
Renalytix AI, Inc.
Observational
2,000
North Carolina
2021-11-22
Recruiting
Celyad Oncology SA
Phase 1
34
Florida
2021-11-22